About IRBM
IRBM is a company based in Pomezia (Italy) founded in 2010 by Ilaria Di Lorenzo and Piero Di Lorenzo. IRBM offers products and services including Small Molecule Discovery, Peptide Drug Discovery, and Antibody Discovery. IRBM operates in a competitive market with competitors including Sai Life Sciences, Acies Bio, Personal Chemistry, NFIL and Bioduro, among others.
- Headquarter Pomezia, Italy
- Founders Ilaria Di Lorenzo, Piero Di Lorenzo
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Irbm S.P.A.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$36.79 K (USD), Grant
Jan 01, 2021
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IRBM
IRBM offers a comprehensive portfolio of products and services, including Small Molecule Discovery, Peptide Drug Discovery, and Antibody Discovery.
Services for identifying and developing small molecule therapeutics
Development of peptide-based drugs for various applications
Platform for discovering and characterizing antibodies
People of IRBM
Unlock access to complete
Unlock access to complete
Funding Insights of IRBM
Investors in IRBM
IRBM has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for IRBM
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IRBM
Investment portfolio details for IRBM
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IRBM
Detailed financials for IRBM
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Irbm Comparisons
Peer comparison for IRBM
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IRBM
IRBM operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sai Life Sciences, Acies Bio, Personal Chemistry, NFIL and Bioduro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
|
|
| Locked | Locked | Locked |
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries
|
|
| Locked | Locked | Locked |
Coherent Synthesis is developed for medicinal and combinatorial chemistry applications.
|
|
| Locked | Locked | Locked |
Fluorinated compounds are synthesized and manufactured customly for various industries.
|
|
| Locked | Locked | Locked |
Integrated drug discovery and development services
|
Detailed competitors of IRBM
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Irbm
Complete news archive for IRBM
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IRBM
IRBM was founded in 2010 and raised its 1st funding round 7 years after it was founded.
IRBM is headquartered in Pomezia, Italy. It is registered at Pomezia, Lazio, Italy.
IRBM was founded in 2010 and is based in Pomezia, Italy. Services in the pharmaceutical sector are delivered, encompassing target validation, hit identification, lead optimization, in vitro pharmacology, preclinical research, peptide therapeutics, and assay development screening. Integrated solutions for drug discovery and early-stage development are supported through these operations, aiding research in life sciences.
IRBM's top competitors include Sai Life Sciences, Acies Bio and Medicilon.
IRBM offers Small Molecule Discovery, Peptide Drug Discovery, and Antibody Discovery.
IRBM has 1 investor. Key investors include European Union.